Sleep Apnea Devices Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Sleep Apnea Devices Market

Sleep Apnea Devices Market by Type, Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces, Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Actigraphy Systems), End User (Sleep Laboratories & Hospitals, Home Care Settings) & Region - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 1181 Jun, 2023, by marketsandmarkets.com

The global sleep apnea devices market in terms of revenue was estimated to be worth $5.8 billion in 2023 and is poised to reach $8.0 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the the growing rising number of companies venturing into the sleep apnea devices and oral appliances market. On the other hand, lack of patient compliance may challenge the growth of market. Whereas, growing demand for home sleep apnea testing to provide growth opportunities for market.

Sleep Apnea Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Sleep Apnea Devices Market

Sleep Apnea Devices Market Dynamics

Driver: Growing awareness of effects of untreated sleep apnea

Countries worldwide are showing a growing awareness of the economic consequences associated with untreated sleep apnea. Obstructive sleep apnea (OSA) is a dangerous disease that can severely impact the heart if left untreated. Long-term undiagnosed sleep apnea can also lead to several health issues such as daytime sleepiness, fatigue, cognitive impairment, cardiovascular problems, metabolic disorders and reduced quality of life. Growing awareness about the economic impact of untreated sleep apnea encourages stakeholders in the healthcare sector (key market players, government bodies, and physician groups) to emphasize the importance of timely diagnosis and effective management of the condition.

Restraint: Alternative therapies and medications

Although positive airway pressure therapy is considered the primary treatment for sleep apnea, ensuring patient compliance with the therapy remains a challenge. Due to the potential difficulty in tolerating traditional PAP therapy, adherence to these devices frequently decline, patients seek alternate options, such as expiratory positive airway pressure (EPAP), hypoglossal nerve stimulation, oral pressure therapy (OPT), and positional therapy. On the other hand, alternative treatment for sleep apnea includes uvulopalatopharyngoplasty, maxillomandibular advancement, and bariatric surgery. Drug-induced sleep endoscopy is increasingly used to locate airway obstruction in patients with OSA.

Opportunity: Increasing focus on telemedicine, mHealth and AI

Several studies have reported that a main predictive factor for long-term CPAP compliance is patient adherence in the first few weeks of treatment. Compliance, support, and follow-up during this period must be prompt. Telemedicine offers this assistance since long waiting lists make it difficult to provide such support. Several studies suggest that patients in the telemedicine group expressed high satisfaction with their care. They especially liked the convenience of a live video visit with a sleep doctor. Instead of replicating traditional visits, mHealth can provide shorter and more frequent assessments; alarm systems on patients’ devices can alert physicians, and mobile applications with simple questionnaires may help with follow-up. The sleep apnea market is likely to show growth owing to these potential benefits offered by telemedicine and mHealth in improving sleep apnea diagnosis and management.

Challenge: Poor compliance associated with CPAP

Lack of patient compliance to CPAP therapy is a crucial factor challenging the growth of the market. Treatment compliance has always been an issue with sleep apnea patients, mainly due to various issues such as lack of affordability and comfort. Patients are also not willing to bear heavy treatment costs due to very weak reimbursements in geographies like Asia (India and China) and the rest of the world. Non-compliance is found to be more rampant among CPAP users. According to several studies, compliance essentially means using a CPAP device for more than 4 hours per night on at least 70% of nights. Failure to comply with CPAP therapy occurred in 25% to 50% of patients who abandoned the therapy within the first four weeks of treatment.

Sleep Apnea Devices Market Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of diagnostic and therapeutic sleep apnea devices. These sleep apnea companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent sleep apnea companies in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

Sleep Apnea Devices Market Ecosystem

In 2022, oral appliances to observe highest growth rate of the sleep apnea devices industry, by product

Based on the products, the global sleep apnea devices market is broadly segmented into positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, adaptive servo-ventilators, and other therapeutic devices. Oral appliances observe the highest growth rate during the forecast period. The high growth rate can be attributed to the enhanced patient comfort, noninvasiveness, small size, and convenience of oral appliances over other therapies.

In 2022, polysomnography segment to dominate the sleep apnea devices industry, by product

Based on product, the sleep apnea devices market is segmented into polysomnography devices, home sleep testing devices, oximeters, actigraphy systems, and sleep screening devices. Polysomnography dominates the market as it is used in PSG tests, the gold standard for diagnosing sleep-related breathing disorders, including OSA.

In 2022, North America to dominate in sleep apnea devices industry

The global sleep apnea devices market is segmented into North America, Europe, Asia Pacific and Rest of World. North America is expected to dominate during the forecast period, primarily due to presence of initiatives such as the CPAP Assistance Program (CAP) and rising number of sleep apnea companies in the US getting private funding for developing and commercializing their sleep apnea products.

Sleep Apnea Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The sleep apnea devices market is dominated by players such ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

Scope of the Sleep Apnea Devices Industry

Report Metric

Details

Market Revenue in 2023

$5.8 billion

Projected Revenue by 2028

$8.0 billion

Revenue Rate

Poised to grow at a CAGR of 6.5%

Market Driver

Growing awareness of effects of untreated sleep apnea

Market Opportunity

Increasing focus on telemedicine, mHealth and AI

This report categorizes the sleep apnea devices market to forecast revenue and analyze trends in each of the following submarkets:

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • Australia
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa

By Product

  • Therapeutic devices
  • Diagnostic devices

By End User

  • Sleep Laboratories & Hospitals
  • Home Care Settings/Individuals

Sleep Apnea Devices Market Regional Forecast:

Recent Developments of Sleep Apnea Devices Industry

  • In 2022, Fisher & Paykel Healthcare (New Zealand) launched Evora Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment in US.
  • In 2021, ResMed (US) acquired MEDIFOX DAN (Germany) the German-based clinical, financial, and operational solutions provider to drive leadership in out-of-hospital software solutions for USD 1 Billion.
  • In 2021, Oventus (Australia) signed a partnership with Aeroflow Healthcare (US). The partnership focuses on providing Oventus’ OSA treatment solutions, including O2Vent Optima, directly to consumers via sleep clinics in the US.
  • In 2020, Koninklijke Philips N.V. (Netherlands) launched the DreamWear Silicone Pillows in North America. These pillows use 3D facial scan data to fit diverse populations.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 38)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
          TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
          FIGURE 1 SLEEP APNEA DEVICES MARKET SCOPE
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 43)
    2.1 RESEARCH DATA 
          FIGURE 2 SLEEP APNEA DEVICES INDUSTRY: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key industry insights
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Breakdown of primary interviews
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.2.1.2 Approach 2: Presentations of sleep apnea companies and primary interviews
                    2.2.1.3 Approach 3: Patient-based approach
                                FIGURE 6 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
           2.2.2 GROWTH FORECAST
           2.2.3 CAGR PROJECTIONS
                    FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
           2.2.4 TOP-DOWN APPROACH
                    FIGURE 8 MARKET: TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 STUDY ASSUMPTIONS 
    2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: MARKET
 
3 EXECUTIVE SUMMARY (Page No. - 56)
    FIGURE 10 SLEEP APNEA DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 SLEEP APNEA DEVICES INDUSTRY FOR THERAPEUTIC DEVICES, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 SLEEP APNEA DEVICES , BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 SLEEP APNEA DEVICES , BY REGION, 2021 VS. 2026 (USD MILLION)
 
4 PREMIUM INSIGHTS (Page No. - 60)
    4.1 MARKET OVERVIEW 
          FIGURE 15 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS GLOBALLY TO DRIVE MARKET
    4.2 SLEEP APNEA DEVICES INDUSTRY, BY REGION (2023–2028) 
          FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    4.3 NORTH AMERICA: MARKET, BY PRODUCT AND COUNTRY (2022) 
          FIGURE 17 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.4 SLEEP APNEA DEVICES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 18 ASIA PACIFIC TO GROW AT HIGHEST RATE DURING STUDY PERIOD
 
5 MARKET OVERVIEW (Page No. - 63)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS (SLEEP APNEA STATISTICS)
          FIGURE 19 SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS (SLEEP APNEA STATISTICS)
                    5.2.1.1 Large pool of undiagnosed sleep apnea patients globally
                                TABLE 3 PREVALENCE OF SLEEP APNEA IN 2020
                    5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies
                                TABLE 4 REIMBURSEMENT CODES AND COSTS OF MAJOR SLEEP APNEA DEVICES BY RESMED
                                TABLE 5 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL
                    5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients
                                TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA
                    5.2.1.4 Growing usage of oral appliances among patients with mild to low-moderate sleep apnea
                                TABLE 7 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA
                    5.2.1.5 Rising number of companies in sleep apnea devices and oral appliances market
           5.2.2 RESTRAINTS (SLEEP APNEA STATISTICS)
                    5.2.2.1 High cost of CPAP machines and minimal insurance access in developing countries
                    5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis
                    5.2.2.3 Alternative therapies and medications for sleep apnea
           5.2.3 OPPORTUNITIES (SLEEP APNEA STATISTICS)
                    5.2.3.1 Growing demand for home sleep apnea tests as cost-saving measure
                    5.2.3.2 Increasing focus on telemedicine, mHealth, and AI
                    5.2.3.3 Increased interest of sleep apnea device manufacturers toward emerging markets
           5.2.4 CHALLENGES (SLEEP APNEA STATISTICS)
                    5.2.4.1 Poor patient compliance associated with CPAP therapy
    5.3 PRICING ANALYSIS 
          TABLE 8 AVERAGE SELLING PRICE OF PAP DEVICES
          TABLE 9 AVERAGE SELLING PRICE OF FACIAL INTERFACES
          TABLE 10 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL APPLIANCES
          TABLE 11 COST OF SLEEP APNEA TESTING METHODS
          TABLE 12 AVERAGE SELLING PRICE OF SLEEP APNEA DEVICES, BY KEY PLAYER
    5.4 VALUE CHAIN ANALYSIS (SLEEP APNEA STATISTICS)
          FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.5 SUPPLY CHAIN ANALYSIS 
          FIGURE 21 DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY OF PROMINENT SLEEP APNEA COMPANIES
    5.6 PORTER’S FIVE FORCES ANALYSIS 
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 THREAT OF SUBSTITUTES
           5.6.3 BARGAINING POWER OF SUPPLIERS
           5.6.4 BARGAINING POWER OF BUYERS
           5.6.5 INTENSITY OF COMPETITIVE RIVALRY
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 22 SLEEP APNEA DEVICES INDUSTRY: ECOSYSTEM ANALYSIS
           5.7.1 ROLE IN ECOSYSTEM
                    FIGURE 23 KEY PLAYERS IN MARKET ECOSYSTEM
    5.8 REGULATORY ANALYSIS 
          TABLE 13 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING SLEEP APNEA DEVICES
           5.8.1 NORTH AMERICA
                    5.8.1.1 US
                                TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               5.8.1.1.1 Reimbursement scenario in US
                    5.8.1.2 Canada
                                TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.8.2 EUROPE
           5.8.3 ASIA PACIFIC
                    5.8.3.1 Japan
                                TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.8.3.2 China
                                TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.8.3.3 India
                    5.8.3.4 Australia
    5.9 PATENT ANALYSIS 
           5.9.1 PATENT TRENDS FOR SLEEP APNEA DEVICES
                     FIGURE 24 PATENT TRENDS FOR SLEEP APNEA DEVICES, JANUARY 2012–DECEMBER 2022
           5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 25 TOP APPLICANTS AND OWNERS (SLEEP APNEA COMPANIES/INSTITUTIONS) FOR SLEEP APNEA ORAL APPLIANCE PATENTS, JANUARY 2012–DECEMBER 2022
    5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
                     FIGURE 26 REVENUE SHIFT FOR SLEEP APNEA DEVICES
    5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 
           TABLE 18 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022–2023
    5.12 TECHNOLOGY ANALYSIS 
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES
                     TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES (%)
           5.13.2 BUYING CRITERIA
                     FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
                     TABLE 20 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
    5.14 TRADE ANALYSIS 
           5.14.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018–2022 (USD MILLION)
           5.14.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018–2022 (USD MILLION)
 
6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA (Page No. - 95)
    6.1 INTRODUCTION 
    6.2 EPIDEMIOLOGICAL ASSESSMENT 
          FIGURE 29 TOP TEN COUNTRIES WITH HIGHEST OBSTRUCTIVE SLEEP APNEA PATIENTS (BASED ON AMERICAN ACADEMY OF SLEEP MEDICINE, 2012)
    6.3 PRESCRIPTION PATTERN ASSESSMENT 
    6.4 ADHERENCE ASSESSMENT 
 
7 ALTERNATE THERAPIES FOR SLEEP APNEA (Page No. - 100)
    7.1 INTRODUCTION 
    7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE 
    7.3 HYPOGLOSSAL NERVE STIMULATION 
    7.4 ORAL PRESSURE THERAPY 
    7.5 POSITIONAL THERAPY 
 
8 SLEEP APNEA DEVICES MARKET, BY TYPE (Page No. - 103)
    8.1 INTRODUCTION 
          TABLE 21 SLEEP APNEA DEVICES INDUSTRY, BY TYPE, 2021–2028 (USD MILLION)
    8.2 THERAPEUTIC DEVICES 
          TABLE 22 MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 23 MARKET FOR THERAPEUTIC DEVICES, BY REGION, 2021–2028 (USD MILLION)
           8.2.1 PAP DEVICES
                    TABLE 24 PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 25 PAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.1.1 CPAP devices
                               8.2.1.1.1 CPAP devices to provide best standard sleep apnea treatment for patients globally
                                              TABLE 26 CPAP DEVICES OFFERED BY KEY PLAYERS
                                              TABLE 27 CPAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.1.2 APAP devices
                               8.2.1.2.1 Increasing patient non-compliance with CPAP devices and growing awareness among sleep specialists to boost segment
                                              TABLE 28 APAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.1.3 BPAP devices
                               8.2.1.3.1 Increased complexity and cost with high product recalls from major sleepa apnea companies to lower adoption
                                              TABLE 29 BPAP DEVICES OFFERED BY KEY PLAYERS
                                              TABLE 30 BPAP DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.2.2 FACIAL INTERFACES
                    TABLE 31 FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 32 FACIAL INTERFACES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.2.1 Masks
                                TABLE 33 MASKS OFFERED BY KEY PLAYERS
                                TABLE 34 MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 35 MASKS MARKET, BY REGION, 2021–2028 (USD MILLION)
                               8.2.2.1.1 Full-face masks
                                             8.2.2.1.1.1 Full-face masks to be most effective for mouth breathers or patients struggling with breathing through nose
                                                               TABLE 36 FULL-FACE MASKS OFFERED BY KEY PLAYERS
                                                               TABLE 37 FULL-FACE MASKS MARKET, BY REGION, 2021–2028 (USD MILLION)
                               8.2.2.1.2 Nasal pillow masks
                                             8.2.2.1.2.1 Greater patient compliance due to smaller size and better fit to drive demand
                                                               TABLE 38 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
                                                               TABLE 39 NASAL PILLOW MASKS MARKET, BY REGION, 2021–2028 (USD MILLION)
                               8.2.2.1.3 Nasal masks
                                             8.2.2.1.3.1 Nasal masks to minimize obstruction of patients’ view and allow patients to wear spectacles
                                                               TABLE 40 NASAL MASKS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.2.2 Cushions
                               8.2.2.2.1 Different product varieties and launches by major sleep apnea companies in past few years to drive market
                                              TABLE 41 CUSHIONS OFFERED BY KEY PLAYERS
                                              TABLE 42 CUSHIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.2.3 ACCESSORIES
                    TABLE 43 ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 44 ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.3.1 Humidifier accessories
                               8.2.3.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing
                                              TABLE 45 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.3.2 Power accessories
                               8.2.3.2.1 Power accessories to manage uninterrupted sleep apnea therapy in absence of power supply
                                              TABLE 46 POWER ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.3.3 Transportation accessories
                               8.2.3.3.1 Convenience associated with transportation accessories while traveling to drive market
                                              TABLE 47 TRANSPORTATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.3.4 Communication accessories
                               8.2.3.4.1 Communication accessories to monitor sleep apnea symptoms through teleconsultations
                                              TABLE 48 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.3.5 Chin restraints
                               8.2.3.5.1 Chin restraints to hold mouth in position during therapy
                                              TABLE 49 CHIN RESTRAINTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.3.6 Other accessories
                                TABLE 50 OTHER ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.2.4 ORAL APPLIANCES
                    TABLE 51 ORAL APPLIANCES OFFERED BY KEY PLAYERS
                    TABLE 52 ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 53 ORAL APPLIANCES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.4.1 Mandibular advancement devices
                               8.2.4.1.1 Mandibular advancement devices to treat mild obstructive sleep apnea and snoring
                                              TABLE 54 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.2.4.2 Tongue-retaining devices
                               8.2.4.2.1 Tongue-retaining devices to be less expensive and reduce both snoring and sleep apnea
                                              TABLE 55 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.2.5 ADAPTIVE SERVO-VENTILATORS
                    8.2.5.1 Improved clinical outcomes associated and better ventilation support as per breathing patterns to fuel market
                                TABLE 56 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.2.6 OTHER THERAPEUTIC DEVICES
                    TABLE 57 OTHER THERAPEUTIC DEVICES OFFERED BY KEY PLAYERS
                    TABLE 58 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.3 DIAGNOSTIC DEVICES 
          TABLE 59 MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 60 MARKET FOR DIAGNOSTIC DEVICES, BY REGION, 2021–2028 (USD MILLION)
           8.3.1 PSG DEVICES
                    TABLE 61 PSG DEVICES OFFERED BY KEY PLAYERS
                    TABLE 62 PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 63 PSG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.3.1.1 Ambulatory PSG devices
                               8.3.1.1.1 Cost-effectiveness and convenience for patients to propel segment
                                              TABLE 64 AMBULATORY PSG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.3.1.2 Clinical PSG devices
                               8.3.1.2.1 Requirement of constant supervision to limit segment growth
                                              TABLE 65 CLINICAL PSG DEVICES OFFERED BY KEY PLAYERS
                                              TABLE 66 CLINICAL PSG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.3.2 HOME SLEEP TESTING DEVICES
                    8.3.2.1 Cost-effectiveness and comfort of home sleep testing to augment segment
                                TABLE 67 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.3.3 OXIMETERS
                    TABLE 68 OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 69 OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.3.3.1 Fingertip oximeters
                               8.3.3.1.1 Lack of precise readings because of injury or slow blood flow due to blood clotting to limit segment
                                              TABLE 70 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
                                              TABLE 71 FINGERTIP OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.3.3.2 Handheld oximeters
                               8.3.3.2.1 Handheld oximeters to be more expensive than fingertips and wrist-worn oximeters
                                              TABLE 72 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
                                              TABLE 73 HANDHELD OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.3.3.3 Wrist-worn oximeters
                               8.3.3.3.1 Small size, long-term usage, and need for overnight monitoring to propel segment
                                              TABLE 74 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
                                              TABLE 75 WRIST-WORN OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    8.3.3.4 TABLEtop oximeters
                               8.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share
                                              TABLE 76 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
                                              TABLE 77 TABLETOP OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.3.4 ACTIGRAPHY SYSTEMS
                    8.3.4.1 Increased focus on assessing actimeter performance to enhance market
                                TABLE 78 ACTIGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
           8.3.5 SLEEP SCREENING DEVICES
                    8.3.5.1 Increasing preference for home-based testing for its efficacy and comfort to drive market
                                TABLE 79 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
                                TABLE 80 SLEEP SCREENING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
 
9 SLEEP APNEA DEVICES MARKET, BY END USER (Page No. - 143)
    9.1 INTRODUCTION 
          TABLE 81 SLEEP APNEA DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.2 SLEEP LABORATORIES, CLINICS, AND HOSPITALS 
           9.2.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
                    TABLE 82 MARKET FOR SLEEP LABORATORIES, CLINICS, AND HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
    9.3 HOME CARE SETTINGS/INDIVIDUALS 
           9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET
                    TABLE 83 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2021–2028 (USD MILLION)
 
10 SLEEP APNEA DEVICES MARKET, BY REGION (Page No. - 148)
     10.1 INTRODUCTION 
             TABLE 84 SLEEP APNEA DEVICES INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
                        FIGURE 30 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
                        TABLE 85 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 86 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 87 NORTH AMERICA: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 88 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 89 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 90 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 91 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 92 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 93 NORTH AMERICA: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 94 NORTH AMERICA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 95 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 96 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.2 US
                        10.2.2.1 Rising availability of grants and funds and increasing trend of home sleep testing to drive market
                                      TABLE 97 KEY SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS IN US
                                      TABLE 98 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 99 US: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 100 US: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 101 US: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 102 US: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 103 US: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 104 US: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 105 US: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 106 US: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 107 US: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 108 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Increasing number of research grants and health programs to propel market
                                      TABLE 109 KEY SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS IN CANADA
                                      TABLE 110 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 111 CANADA: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 112 CANADA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 113 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 114 CANADA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 115 CANADA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 116 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 117 CANADA: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 118 CANADA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 119 CANADA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 120 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.3 EUROPE 
             10.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
                        TABLE 121 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 122 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 123 EUROPE: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 124 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 125 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 126 EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 127 EUROPE: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 128 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 129 EUROPE: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 130 EUROPE: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 131 EUROPE: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 132 EUROPE: SLEEP APNEA DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 High prevalence of obstructive sleep apnea primarily due to smoking to fuel market
                                      TABLE 133 KEY SLEEP APNEA PRODUCTS BY MAJOR PLAYERS IN GERMANY
                                      TABLE 134 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 135 GERMANY: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 136 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 137 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 138 GERMANY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 139 GERMANY: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 140 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 141 GERMANY: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 142 GERMANY: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 143 GERMANY: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 144 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Rising geriatric population to increase incidence of sleep apnea
                                      TABLE 145 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 146 FRANCE: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 147 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 148 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 149 FRANCE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 150 FRANCE: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 151 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 152 FRANCE: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 153 FRANCE: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 154 FRANCE: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 155 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 UK
                        10.3.4.1 Rising awareness among patients and increasing number of sleep service groups to support market
                                      TABLE 156 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 157 UK: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 158 UK: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 159 UK: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 160 UK: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 161 UK: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 162 UK: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 163 UK: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 164 UK: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 165 UK: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 166 UK: SLEEP APNEA DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Growing prevalence of sleep apnea and increasing awareness among patients regarding ill effects of disease to aid market
                                      TABLE 167 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 168 ITALY: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 169 ITALY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 170 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 171 ITALY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 172 ITALY: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 173 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 174 ITALY: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 175 ITALY: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 176 ITALY: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 177 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Increasing initiatives for social awareness regarding illness and treatment by regional organizations to drive market
                                      TABLE 178 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 179 SPAIN: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 180 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 181 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 182 SPAIN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 183 SPAIN: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 184 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 185 SPAIN: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 186 SPAIN: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 187 SPAIN: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 188 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 189 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 190 REST OF EUROPE: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 191 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 192 REST OF EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 193 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 194 REST OF EUROPE: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 195 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 196 REST OF EUROPE: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 197 REST OF EUROPE: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 198 REST OF EUROPE: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 199 REST OF EUROPE: SLEEP APNEA DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
                        FIGURE 31 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
                        TABLE 200 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 201 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 202 ASIA PACIFIC: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 203 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 204 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 205 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 206 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 207 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 208 ASIA PACIFIC: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 209 ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 210 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 211 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to aid market
                                      TABLE 212 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 213 JAPAN: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 214 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 215 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 216 JAPAN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 217 JAPAN: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 218 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 219 JAPAN: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 220 JAPAN: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 221 JAPAN: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 222 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 CHINA
                        10.4.3.1 Growing adult obesity rates and expanding geriatric population to propel market
                                      TABLE 223 CHINA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 224 CHINA: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 225 CHINA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 226 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 227 CHINA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 228 CHINA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 229 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 230 CHINA: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 231 CHINA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 232 CHINA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 233 CHINA: SLEEP APNEA DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 High prevalence of sleep apnea and increased number of awareness programs to drive market
                                      TABLE 234 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 235 AUSTRALIA: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 236 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 237 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 238 AUSTRALIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 239 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 240 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 241 AUSTRALIA: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 242 AUSTRALIA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 243 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 244 AUSTRALIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 245 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 246 REST OF ASIA PACIFIC: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 247 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 248 REST OF ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 249 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 250 REST OF ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 251 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 252 REST OF ASIA PACIFIC: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 253 REST OF ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 254 REST OF ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 255 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.5 REST OF THE WORLD 
             TABLE 256 REST OF THE WORLD: SLEEP APNEA DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
             TABLE 257 REST OF THE WORLD: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 258 REST OF THE WORLD: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 259 REST OF THE WORLD: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 260 REST OF THE WORLD: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 261 REST OF THE WORLD: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 262 REST OF THE WORLD: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 263 REST OF THE WORLD: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 264 REST OF THE WORLD: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 265 REST OF THE WORLD: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 266 REST OF THE WORLD: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 267 REST OF THE WORLD: SLEEP APNEA DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             10.5.1 LATIN AMERICA
                        10.5.1.1 Increasing obesity rate to augment prevalence of sleep apnea
                        10.5.1.2 Latin America: Impact of economic recession
                                      TABLE 268 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 269 LATIN AMERICA: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 270 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 271 LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 272 LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 273 LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 274 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 275 LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 276 LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 277 LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 278 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.2 MIDDLE EAST & AFRICA
                        10.5.2.1 Dearth of awareness about sleep apnea among general population to limit market
                        10.5.2.2 Middle East & Africa: Impact of economic recession
                                      TABLE 279 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 280 MIDDLE EAST & AFRICA: MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 281 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 282 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 283 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 284 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 285 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 286 MIDDLE EAST & AFRICA: MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 287 MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 288 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 289 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 234)
     11.1 OVERVIEW 
     11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN SLEEP APNEA DEVICES MARKET 
             TABLE 290 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA DEVICE MANUFACTURERS
     11.3 REVENUE ANALYSIS 
             FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS
     11.4 MARKET SHARE ANALYSIS 
             TABLE 291 SLEEP APNEA DEVICES INDUSTRY: DEGREE OF COMPETITION
             FIGURE 33 MARKET SHARE ANALYSIS, 2022
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 34 MARKET: COMPANY EVALUATION QUADRANT
     11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS) 
             11.6.1 PROGRESSIVE SLEEP APNEA COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE SLEEP APNEA COMPANIES
             11.6.4 DYNAMIC SLEEP APNEA COMPANIES
                        FIGURE 35 MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
     11.7 COMPANY FOOTPRINT ANALYSIS 
             TABLE 292 COMPANY FOOTPRINT OF PLAYERS IN MARKET
             TABLE 293 COMPANY PRODUCT FOOTPRINT
             TABLE 294 COMPANY REGIONAL FOOTPRINT
     11.8 COMPETITIVE BENCHMARKING 
             TABLE 295 SLEEP APNEA DEVICES INDUSTRY: DETAILED LIST OF KEY START-UPS/SMES
     11.9 COMPETITIVE SCENARIO 
             11.9.1 KEY PRODUCT LAUNCHES AND APPROVALS
                        TABLE 296 MARKET: KEY PRODUCT LAUNCHES AND APPROVALS, 2020–2023
             11.9.2 KEY DEALS
                        TABLE 297 MARKET: KEY DEALS, 2020–2023
             11.9.3 OTHER KEY DEVELOPMENTS
                        TABLE 298 SLEEP APNEA DEVICES INDUSTRY: OTHER KEY DEVELOPMENTS, 2020–2023
 
12 COMPANY PROFILES (Page No. - 248)
     12.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             12.1.1 RESMED
                        TABLE 299 RESMED: COMPANY OVERVIEW
                        FIGURE 36 RESMED: COMPANY SNAPSHOT (2022)
             12.1.2 KONINKLIJKE PHILIPS N.V.
                        TABLE 300 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             12.1.3 FISHER & PAYKEL HEALTHCARE LIMITED
                        TABLE 301 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
                        FIGURE 38 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022)
             12.1.4 INSPIRE MEDICAL SYSTEMS, INC.
                        TABLE 302 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
                        FIGURE 39 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
             12.1.5 SOMNOMED
                        TABLE 303 SOMNOMED: COMPANY OVERVIEW
                        FIGURE 40 SOMNOMED: COMPANY SNAPSHOT (2022)
             12.1.6 OVENTUS MEDICAL
                        TABLE 304 OVENTUS MEDICAL: COMPANY OVERVIEW
                        FIGURE 41 OVENTUS MEDICAL: COMPANY SNAPSHOT (2022)
             12.1.7 COMPUMEDICS LIMITED
                        TABLE 305 COMPUMEDICS LIMITED: COMPANY OVERVIEW
                        FIGURE 42 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2022)
             12.1.8 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.
                        TABLE 306 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: COMPANY OVERVIEW
             12.1.9 DRIVE DEVILBISS HEALTHCARE
                        TABLE 307 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW
             12.1.10 BMC MEDICAL CO., LTD.
                        TABLE 308 BMC MEDICAL CO., LTD.: COMPANY OVERVIEW
             12.1.11 BRAEBON MEDICAL CORPORATION
                        TABLE 309 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
             12.1.12 WHOLE YOU, INC.
                        TABLE 310 WHOLE YOU, INC.: COMPANY OVERVIEW
             12.1.13 PANTHERA DENTAL
                        TABLE 311 PANTHERA DENTAL: COMPANY OVERVIEW
             12.1.14 MYERSON LLC
                        TABLE 312 MYERSON LLC: COMPANY OVERVIEW
             12.1.15 PROSOMNUS SLEEP TECHNOLOGIES
                        TABLE 313 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
                        FIGURE 43 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2022)
     12.2 OTHER PLAYERS 
             12.2.1 NIDEK MEDICAL INDIA
             12.2.2 TOMED GMBH
             12.2.3 LIVANOVA
             12.2.4 INVACARE CORPORATION
             12.2.5 MPOWRX HEALTH & WELLNESS
             12.2.6 NIHON KOHDEN
             12.2.7 NATUS MEDICAL INCORPORATED
             12.2.8 VIVOS THERAPEUTICS
             12.2.9 AIRWAY MANAGEMENT
             12.2.10 APNEA SCIENCES
 
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted sleep apnea companies.
 
13 APPENDIX (Page No. - 293)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

The objective of the study is analyze the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies developments such as acquisitions, product launches, expansions, collaborations, agreements and partnerships of the leading players, the competitive landscape of the sleep apnea devices industry to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were use to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the  usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the sleep apnea devices industry. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the sleep apnea devices industry scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such clinical laboratories, hospitals, and academic & research institutes) and supply-side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, and Rest of the World. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Sleep Apnea Devices Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

ResMed

General Manager

Fisher & Paykel Healthcare

Senior Product Manager

Inspire Medical Systems, Inc.

Regional Manager

SomnoMed

General Manager of Sales

Market Size Estimation

All major product manufacturers offering various sleep apnea were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value sleep apnea devices market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of sleep apnea devices industry at the regional and country-level 
  • Relative adoption pattern of each sleep apnea devices market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country-level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Sleep apnea devices Market Size: Botton Up Approach

Sleep Apnea Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Sleep apnea devices market Size: Top Down Approach

Sleep Apnea Devices Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact sleep apnea statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Sleep apnea devices industry.

Market Definition

Sleep apnea involves abnormal pauses in breathing, ranging from a few seconds to minutes, or the occurrence of an abnormally slow breathing rate. Sleep apnea devices are used to force air into the nasal passages at high pressure to overcome obstructions in the airway and stimulate normal breathing.

Key Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To define, describe, and forecast the sleep apnea devices market by type, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices industry
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
  • To profile the key players and comprehensively analyze their sleep apnea device portfolios, market positions, and core competencies
  • To track and analyze company developments such as product approvals and launches, expansions, agreements, and acquisitions in the sleep apnea devices market

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Sleep apnea devices industry
  • Profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Sleep apnea devices Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1181
Published ON
Jun, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Sleep Apnea Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback